103 related articles for article (PubMed ID: 17978301)
21. Oxidative damage and cutaneous reactions during radiotherapy in combination with cetuximab.
Skvortsova I
Radiother Oncol; 2009 Feb; 90(2):281-2. PubMed ID: 19150740
[No Abstract] [Full Text] [Related]
22. Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.
Studer G; Brown M; Salgueiro EB; Schmückle H; Romancuk N; Winkler G; Lee SJ; Sträuli A; Kissling B; Dummer R; Glanzmann C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):110-7. PubMed ID: 20732757
[TBL] [Abstract][Full Text] [Related]
23. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer.
Pryor DI; Porceddu SV; Burmeister BH; Guminski A; Thomson DB; Shepherdson K; Poulsen M
Radiother Oncol; 2009 Feb; 90(2):172-6. PubMed ID: 18976827
[TBL] [Abstract][Full Text] [Related]
24. Stevens-Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer.
Urosevic-Maiwald M; Harr T; French LE; Dummer R
Int J Dermatol; 2012 Jul; 51(7):864-7. PubMed ID: 22715836
[TBL] [Abstract][Full Text] [Related]
25. Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis.
Birnbaum A; Dipetrillo T; Rathore R; Anderson E; Wanebo H; Puthwala Y; Joyce D; Safran H; Henderson D; Kennedy T; Ready N; Sio TT
Am J Clin Oncol; 2010 Apr; 33(2):144-7. PubMed ID: 19786848
[TBL] [Abstract][Full Text] [Related]
26. Molecular targeted therapies in all histologies of head and neck cancers: an update.
Razak AR; Siu LL; Le Tourneau C
Curr Opin Oncol; 2010 May; 22(3):212-20. PubMed ID: 20173639
[TBL] [Abstract][Full Text] [Related]
27. Clinical trials, referral resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck.
Conley BA; Gore-Langton RE; Cheson BD
Oncology (Williston Park); 2000 Apr; 14(4):553-4, 559, 561. PubMed ID: 10826315
[No Abstract] [Full Text] [Related]
28. Cetuximab plus radiotherapy for head and neck cancer.
Hartig F; Pechlaner C
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710909
[No Abstract] [Full Text] [Related]
29. Combination treatment of Cetuximab and photodynamic therapy in SNU-1041 squamous cancer cell line.
Kim SG; Hong JW; Boo SH; Kim MG; Lee KD; Ahn JC; Hwang HJ; Shin JI; Lee SJ; Oh JK; Chung PS
Oncol Rep; 2009 Oct; 22(4):701-8. PubMed ID: 19724846
[TBL] [Abstract][Full Text] [Related]
30. Severe radiation dermatitis in patients with locally advanced head and neck cancer treated with concurrent radiation and cetuximab.
Koutcher LD; Wolden S; Lee N
Am J Clin Oncol; 2009 Oct; 32(5):472-6. PubMed ID: 19487913
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of hyaluronic acid gel (Jalosome soothing gel) for the treatment of radiodermatitis in a patient receiving head and neck radiotherapy associated with cetuximab: A case report and review.
Presta G; Puliatti A; Bonetti L; Tolotti A; Sari D; Valcarenghi D
Int Wound J; 2019 Dec; 16(6):1433-1439. PubMed ID: 31475472
[TBL] [Abstract][Full Text] [Related]
32. A docetaxel-induced rash on a radiotherapy port.
Quatresooz P; Piérard GE
Am J Clin Dermatol; 2010; 11(5):367-9. PubMed ID: 20504047
[No Abstract] [Full Text] [Related]
33. Infusion chemotherapy and radiation therapy: a new approach with encouraging results in anal, esophageal, head and neck and cervical carcinoma.
Maguire LC; Mendiondo OA; Medina WD; Cronin JD; Meeker WR; Cornett A
J Ky Med Assoc; 1985 Dec; 83(12):653-5. PubMed ID: 4078485
[No Abstract] [Full Text] [Related]
34. Cetuximab-related radiation dermatitis in head-and-neck cancer patients: in regard to Studer et al. (Int J Radiat Oncol Biol Phys in press).
Russi EG; Numico G; Merlano MC; Pinto C
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1278; author reply 1278-9. PubMed ID: 21353162
[No Abstract] [Full Text] [Related]
35. Cetuximab plus radiotherapy in patients with unresectable locally advanced squamous cell carcinoma of head and neck region--a open labelled single arm phase II study.
Dattatreya S; Goswami C
Indian J Cancer; 2011; 48(2):154-7. PubMed ID: 21768658
[TBL] [Abstract][Full Text] [Related]
36. Head and neck squamous cell carcinomas.
Fayette J
Anticancer Drugs; 2011 Aug; 22(7):585. PubMed ID: 21705866
[No Abstract] [Full Text] [Related]
37. [Three cases of head and neck cancer made resectable by hyperthermo-chemo-radiotherapy].
Fujimura T; Yonemura Y; Kamata T; Takegawa S; Sugiyama K; Nishimura G; Miyata R; Yamaguchi A; Miyazaki I; Nakajima K
Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1322-7. PubMed ID: 3430022
[No Abstract] [Full Text] [Related]
38. Evaluation of quality of life and organ function in head and neck squamous cell carcinoma.
Martino R; Ringash J
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1239-56, x. PubMed ID: 19010271
[TBL] [Abstract][Full Text] [Related]
39. Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?
Bernier J; Schneider D
Eur J Cancer; 2007 Jan; 43(1):35-45. PubMed ID: 17098420
[TBL] [Abstract][Full Text] [Related]
40. Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: Ready for routine clinical practice?
Agarwal JP; Gupta T; Kalyani N; Budrukkar A; Laskar SG; Murthy V; Kumar P; Narohna V; Pai P; Chaturvedi P; D'cruz AK
Indian J Cancer; 2011; 48(2):148-53. PubMed ID: 21768657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
